sponsored
PatientsVille.com Logo

PatientsVille

Metronidazole and Calcium

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectMetronidazoleCalcium
DIARRHOEA3.5% 2.9%
NAUSEA3.4% 3.3%
FATIGUE1.9% 3.4%
DRUG INEFFECTIVE2.7% 2.7%
PAIN2.2% 2.5%
VOMITING2.5% 1.9%
PYREXIA2.5% 1.5%
DIZZINESS2.1% 2.3%
DYSPNOEA1.9% 2.3%
ARTHRALGIA1.1% 2.3%
HEADACHE2.2% 2.2%
ASTHENIA1.5% 2.2%
FALL0.8% 2.1%
PAIN IN EXTREMITY1.1% 2%
ABDOMINAL PAIN1.8% 1.1%
MALAISE1.5% 1.7%
OFF LABEL USE1% 1.7%
RASH1.6% 1.3%
DRUG INTERACTION1.6% 0.7%
PNEUMONIA1.2% 1.5%
BACK PAIN0.8% 1.5%
ANXIETY1.4% 1%
WEIGHT DECREASED0.9% 1.4%
DRUG HYPERSENSITIVITY1.4% 0.7%
PRURITUS1.3% 1.3%
ANAEMIA1.3% 1.1%
HYPOTENSION1.3% 0.9%
MUSCLE SPASMS0.7% 1.3%
CONFUSIONAL STATE1.3% 0.7%
MYALGIA0.6% 1.3%
INSOMNIA0.9% 1.2%
DEATH0.9% 1.2%
COUGH0.6% 1.2%
SEPSIS1.2% 0.6%
CONSTIPATION0.6% 1.2%
GAIT DISTURBANCE0.8% 1.1%
PARAESTHESIA1.1% 0.8%
RENAL FAILURE1.1% 0.7%
ACUTE KIDNEY INJURY1.1% 0%
CLOSTRIDIUM DIFFICILE INFECTION1.1% 0%
CONDITION AGGRAVATED1% 0.9%
DEPRESSION1% 0.9%
ABDOMINAL PAIN UPPER1% 0.9%
DECREASED APPETITE0.9% 1%
URINARY TRACT INFECTION0.8% 1%
CHEST PAIN0.8% 1%
FEELING ABNORMAL0.6% 1%
PATHOGEN RESISTANCE1% 0%
HYPERTENSION0.8% 0.9%
DEHYDRATION0.8% 0.9%
OEDEMA PERIPHERAL0.6% 0.9%
SEPTIC SHOCK0.9% 0%
HYPOAESTHESIA0.7% 0.8%
ERYTHEMA0.8% 0.7%
MUSCULAR WEAKNESS0.6% 0.8%
HYPERSENSITIVITY0.8% 0.6%
NEUTROPENIA0.8% 0.5%
PULMONARY EMBOLISM0.8% 0.5%
THROMBOCYTOPENIA0.8% 0.5%
NEUROPATHY PERIPHERAL0.8% 0.4%
DRUG DOSE OMISSION0% 0.8%
INJECTION SITE PAIN0% 0.8%
WEIGHT INCREASED0% 0.8%
TOXIC ENCEPHALOPATHY0.8% 0%
DYSARTHRIA0.8% 0%
ALOPECIA0% 0.8%
TOXICITY TO VARIOUS AGENTS0.8% 0%
INJURY0.8% 0%
CLOSTRIDIUM DIFFICILE COLITIS0.8% 0%
SOMNOLENCE0.7% 0.7%
TREMOR0.7% 0.7%
HAEMOGLOBIN DECREASED0.6% 0.7%
ABDOMINAL DISCOMFORT0.5% 0.7%
INFECTION0.7% 0.5%
DYSPHAGIA0.7% 0.4%
BLOOD PRESSURE INCREASED0% 0.7%
NASOPHARYNGITIS0% 0.7%
HAEMORRHAGE0.7% 0%
TACHYCARDIA0.7% 0%
URTICARIA0.7% 0%
DEEP VEIN THROMBOSIS0.7% 0%
ALANINE AMINOTRANSFERASE INCREASED0.7% 0%
DYSGEUSIA0.7% 0%
ANAPHYLACTIC REACTION0.7% 0%
RESPIRATORY FAILURE0.7% 0%
CHRONIC KIDNEY DISEASE0.7% 0%
GENERAL PHYSICAL HEALTH DETERIORATION0.7% 0%
ATRIAL FIBRILLATION0.6% 0.6%
RENAL FAILURE ACUTE0.6% 0.5%
CHILLS0.5% 0.6%
ABDOMINAL DISTENSION0.6% 0.5%
BLOOD GLUCOSE INCREASED0% 0.6%
CONTUSION0% 0.6%
BONE PAIN0% 0.6%
PERIPHERAL SWELLING0% 0.6%
JOINT SWELLING0% 0.6%
MYOCARDIAL INFARCTION0% 0.6%
FLUSHING0% 0.6%
EXPOSURE DURING PREGNANCY0.6% 0%
ENCEPHALOPATHY0.6% 0%
PANCYTOPENIA0.6% 0%
CEREBROVASCULAR ACCIDENT0% 0.6%
NEUROTOXICITY0.6% 0%
INTERNATIONAL NORMALISED RATIO INCREASED0.6% 0%
PALPITATIONS0.5% 0.5%
GASTROOESOPHAGEAL REFLUX DISEASE0% 0.5%
INJECTION SITE ERYTHEMA0% 0.5%
SYNCOPE0% 0.5%
ARTHRITIS0% 0.5%
MUSCULOSKELETAL PAIN0% 0.5%
RHEUMATOID ARTHRITIS0% 0.5%
WHITE BLOOD CELL COUNT DECREASED0% 0.5%
DYSPEPSIA0% 0.5%
BALANCE DISORDER0% 0.5%
LOSS OF CONSCIOUSNESS0% 0.5%
SINUSITIS0% 0.5%
VISION BLURRED0% 0.5%
CARDIAC ARREST0.5% 0%
HEPATITIS0.5% 0%
ATAXIA0.5% 0%
OEDEMA0.5% 0%
HYPERHIDROSIS0% 0.5%
PLEURAL EFFUSION0.5% 0%
COLITIS0.5% 0%
SWELLING FACE0.5% 0%
ASPARTATE AMINOTRANSFERASE INCREASED0.5% 0%
EMOTIONAL DISTRESS0.5% 0%
MEMORY IMPAIRMENT0% 0.5%
PLATELET COUNT DECREASED0% 0.4%
GASTROINTESTINAL HAEMORRHAGE0% 0.4%
BRONCHITIS0% 0.4%
HEART RATE INCREASED0% 0.4%
CHEST DISCOMFORT0% 0.4%

New treatments are found every day. View current Metronidazole research studies and Calcium clinical trials

1